CN105031552A - Traditional Chinese medicine composition for treating gynecological tumors - Google Patents

Traditional Chinese medicine composition for treating gynecological tumors Download PDF

Info

Publication number
CN105031552A
CN105031552A CN201510580257.3A CN201510580257A CN105031552A CN 105031552 A CN105031552 A CN 105031552A CN 201510580257 A CN201510580257 A CN 201510580257A CN 105031552 A CN105031552 A CN 105031552A
Authority
CN
China
Prior art keywords
parts
chinese medicine
herba
medicine composition
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510580257.3A
Other languages
Chinese (zh)
Inventor
李万青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510580257.3A priority Critical patent/CN105031552A/en
Publication of CN105031552A publication Critical patent/CN105031552A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating gynecological tumors. The traditional Chinese medicine composition for treating the gynecological tumors is prepared by, by weight, 20-35 parts of curcuma zedoary, 20-35 parts of indigo naturalis, 15-25 parts of black nightshade,15-25 parts of cortex albiziae, 15-25 parts of loofah sponge,15-25 parts of silkworm larva, 10-15 parts of glossy privet fruits, 10-15 parts of Chinese wolfberry fruits, 10-15 parts of common burreed rhizomes,10-15 parts of Chinese angelica, 10-15 parts of stephania, 5-10 parts of panax japonicus, 5-10 parts of acorus tatarinowii, 5-10 parts of edible tulip, 5-10 parts of motherwort, 5-10 parts of mangnolia officinalis barks, 5-10 parts of glabrous sarcandra herb, 5-10 parts of humifuse euphorbia herb and 5-10 parts of licorice. The traditional Chinese medicine composition has the effects of removing stasis, eliminating stagnation, activating meridians to stop pain, clearing away heat and toxic materials, enriching and regulating blood, tonifying the spleen, removing qi stagnation, strengthening body resistance and tonifying qi, is used for treating various gynecological tumors, especially ovarian cancer, cervical cancer, endometrial cancer and uterine fibroids, and is free of toxic and side effects and remarkable in treating effect.

Description

A kind of Chinese medicine composition for the treatment of gynecological tumor
Technical field
The present invention relates to a kind of Chinese medicine composition, in particular to a kind of Chinese medicine composition for the treatment of gynecological tumor.
Background technology
The sickness rate of the large malignant tumor (cervical cancer, carcinoma of endometrium, ovarian cancer) of gynecological three occupies the 3rd, 5,8 respectively in female cancer patients, and accounts for the 2nd, 7,9 in developing country.In China, the sickness rate of the large malignant tumor of gynecological three is obvious ascendant trend, and age also rejuvenation increasingly occurs.Motherland's medical science is thought, outer by damp and hot, and the evil cohesion of poison, blocks collaterals of the uterus; Most due to long anxiety and rage.Gynaecologic reproductive system tumor belongs to traditional Chinese medical science “ mass in the abdomen ", " gathering ", " metrorrhagia ", the category such as " leukorrhagia ".Theory of Chinese medical science is thought, the basic reason that gynecological tumor forms tumor body is because of internal injury caused by excess of seven emotions, disharmony between QI and blood, and function is disorderly, drinking and eating irregularly, and yin and yang imbalance etc. cause phlegm-damp to stagnate, obstruction of meridian; Or ferritic is not enough, the heresy of six climate exopathogens and the gas of noxious dampness are taken advantage of a weak point, and cause qi depression to blood stasis eventually and form.
Compare with conventional cancer therapy, Chinese medicine has the little advantage even had no side effect of toxic and side effects.In addition, the relation of Chinese medicine more more holistic and local in treatment of cancer, wherein, the chief of the treatment of late stage particularly traditional Chinese medical science.Traditional Chinese Medicine Anti tumor has stronger organic conception, can make up operative treatment, radiotherapy, chemotherapeutical deficiency, and not affect labour force.Cancer patient is while local conditions takes a turn for the better, and overall health of patients also improves, and even can be competent at daily work.In addition, Chinese medicine side effect is less, does not have the side effect of bone marrow depression aspect, does not also have serious impact to digestive tract; Relatively more cheap economically, take and facilitate.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of gynecological tumor, based on the dialectical prescription of tcm theory, there is eliminating stasis and resolving masses, removing obstruction in the collateral to relieve pain, heat-clearing and toxic substances removing, enrich blood and adjust effect of blood, spleen invigorating removing food stagnancy, righting QI invigorating, be used for the treatment of the various tumor of gynecological, especially ovarian cancer, cervical cancer, carcinoma of endometrium and hysteromyoma, have no side effect, therapeutic effect is remarkable.
Concrete, one aspect of the present invention provides a kind of Chinese medicine composition for the treatment of gynecological tumor, is made up: Rhizoma Curcumae, Indigo Naturalis, Herba Solani Nigri of following bulk drugs.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 20-35 part, Indigo Naturalis 20-35 part, Herba Solani Nigri 15-25 part.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 20-35 part, Indigo Naturalis 20-35 part, Herba Solani Nigri 15-25 part, Cortex Albiziae 15-25 part, Retinervus Luffae Fructus 15-25 part.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 20-35 part, Indigo Naturalis 20-35 part, Herba Solani Nigri 15-25 part, Cortex Albiziae 15-25 part, Retinervus Luffae Fructus 15-25 part, Bombyx Batryticatus 15-25 part, Fructus Ligustri Lucidi 10-15 part, Fructus Lycii 10-15 part, Rhizoma Sparganii 10-15 part, Radix Angelicae Sinensis 10-15 part, Radix Stephaniae Japonicae 10-15 part, Rhizoma Panacis Japonici 5-10 part, Rhizoma Acori Graminei 5-10 part, Pseudobulbus Cremastrae Seu Pleiones 5-10 part, Herba Leonuri 5-10 part, Cortex Magnoliae Officinalis 5-10 part, Herba Pileae Scriptae 5-10 part, Herba Euphorbiae Humifusae 5-10 part, Radix Glycyrrhizae 5-10 part.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 20 parts, Indigo Naturalis 20 parts, Herba Solani Nigri 25 parts, Cortex Albiziae 25 parts, Retinervus Luffae Fructus 15 parts, Bombyx Batryticatus 25 parts, Fructus Ligustri Lucidi 10 parts, Fructus Lycii 15 parts, Rhizoma Sparganii 15 parts, Radix Angelicae Sinensis 10 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 5 parts, Rhizoma Acori Graminei 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 10 parts, Herba Pileae Scriptae 5 parts, Herba Euphorbiae Humifusae 10 parts, 5 parts, Radix Glycyrrhizae.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 30 parts, Indigo Naturalis 25 parts, Herba Solani Nigri 20 parts, Cortex Albiziae 23 parts, Retinervus Luffae Fructus 20 parts, Bombyx Batryticatus 20 parts, Fructus Ligustri Lucidi 13 parts, Fructus Lycii 12 parts, Rhizoma Sparganii 10 parts, Radix Angelicae Sinensis 13 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 6 parts, Rhizoma Acori Graminei 8 parts, Pseudobulbus Cremastrae Seu Pleiones 9 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 8 parts, Herba Pileae Scriptae 9 parts, Herba Euphorbiae Humifusae 7 parts, 6 parts, Radix Glycyrrhizae.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 25 parts, Indigo Naturalis 35 parts, Herba Solani Nigri 23 parts, Cortex Albiziae 24 parts, Retinervus Luffae Fructus 23 parts, Bombyx Batryticatus 15 parts, Fructus Ligustri Lucidi 11 parts, Fructus Lycii 13 parts, Rhizoma Sparganii 14 parts, Radix Angelicae Sinensis 12 parts, Radix Stephaniae Japonicae 11 parts, Rhizoma Panacis Japonici 9 parts, Rhizoma Acori Graminei 6 parts, Pseudobulbus Cremastrae Seu Pleiones 6 parts, Herba Leonuri 8 parts, Cortex Magnoliae Officinalis 7 parts, Herba Pileae Scriptae 6 parts, Herba Euphorbiae Humifusae 8 parts, 9 parts, Radix Glycyrrhizae.
Another aspect of the present invention provides a kind of preparation method for the treatment of the Chinese medicine composition of gynecological tumor, it is characterized in that, the preparation method of this Chinese medicine composition comprises the following steps:
(1) Rhizoma Acori Graminei, Rhizoma Curcumae steam distillation extract volatile oil, obtain mixture of volatile oil, and it are for subsequent use to collect aqueous solution;
(2) Indigo Naturalis, Herba Solani Nigri, Retinervus Luffae Fructus, Fructus Ligustri Lucidi, Rhizoma Sparganii, Radix Stephaniae Japonicae, Pseudobulbus Cremastrae Seu Pleiones, Herba Pileae Scriptae, Herba Euphorbiae Humifusae are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C be 1.15-1.25 extractum ( );
(3) Cortex Albiziae, Bombyx Batryticatus, Fructus Lycii, Radix Angelicae Sinensis, Rhizoma Panacis Japonici, Herba Leonuri, Cortex Magnoliae Officinalis, Radix Glycyrrhizae are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C be 1.15-1.25 extractum ( );
(4) by step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, to obtain final product.
In a specific embodiment of the present invention, described preparation method, wherein adds the soak by water 3 times accounting for gross weight 10 times amount, each 1.5 hours in step (2); Account in step (3) in the alcoholic solution of 85% of gross weight 10 times amount and extract 2 times, each 3 hours.
Chinese medicine composition of the present invention can also be prepared according to the conventional method of the field of Chinese medicines, comprises soak by water etc.The Chinese medicine composition for the treatment of gynecological tumor of the present invention, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.Described oral formulations is capsule, pill, powder, tablet, granule.
Chinese medicine composition of the present invention, based on tcm theory dialectical prescription, there is eliminating stasis and resolving masses, removing obstruction in the collateral to relieve pain, heat-clearing and toxic substances removing, enrich blood and adjust effect of blood, spleen invigorating removing food stagnancy, righting QI invigorating, be used for the treatment of the various tumor of gynecological, especially ovarian cancer, cervical cancer, carcinoma of endometrium and hysteromyoma, have no side effect, therapeutic effect is remarkable.
Detailed description of the invention
Embodiment 1:
A kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 20 parts, Indigo Naturalis 20 parts, Herba Solani Nigri 25 parts, Cortex Albiziae 25 parts, Retinervus Luffae Fructus 15 parts, Bombyx Batryticatus 25 parts, Fructus Ligustri Lucidi 10 parts, Fructus Lycii 15 parts, Rhizoma Sparganii 15 parts, Radix Angelicae Sinensis 10 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 5 parts, Rhizoma Acori Graminei 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 10 parts, Herba Pileae Scriptae 5 parts, Herba Euphorbiae Humifusae 10 parts, 5 parts, Radix Glycyrrhizae;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 2:
A kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 20 parts, Indigo Naturalis 20 parts, Herba Solani Nigri 25 parts, Cortex Albiziae 25 parts, Retinervus Luffae Fructus 15 parts, Bombyx Batryticatus 25 parts, Fructus Ligustri Lucidi 10 parts, Fructus Lycii 15 parts, Rhizoma Sparganii 15 parts, Radix Angelicae Sinensis 10 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 5 parts, Rhizoma Acori Graminei 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 10 parts, Herba Pileae Scriptae 5 parts, Herba Euphorbiae Humifusae 10 parts, 5 parts, Radix Glycyrrhizae;
Preparation method comprises the following steps:
(1) Rhizoma Acori Graminei, Rhizoma Curcumae steam distillation extract volatile oil, obtain mixture of volatile oil, and it are for subsequent use to collect aqueous solution;
(2) Indigo Naturalis, Herba Solani Nigri, Retinervus Luffae Fructus, Fructus Ligustri Lucidi, Rhizoma Sparganii, Radix Stephaniae Japonicae, Pseudobulbus Cremastrae Seu Pleiones, Herba Pileae Scriptae, Herba Euphorbiae Humifusae are added the soak by water 3 times accounting for gross weight 10 times amount, each 2 hours, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C be 1.15-1.25 extractum ( );
(3) Cortex Albiziae, Bombyx Batryticatus, Fructus Lycii, Radix Angelicae Sinensis, Rhizoma Panacis Japonici, Herba Leonuri, Cortex Magnoliae Officinalis, Radix Glycyrrhizae are added account for gross weight 15 times amount 85% alcoholic solution in extract 3 times, each 2 hours, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C be 1.15-1.25 extractum ( );
(4) by step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, incapsulate and get final product.
Embodiment 3:
A kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 30 parts, Indigo Naturalis 25 parts, Herba Solani Nigri 20 parts, Cortex Albiziae 23 parts, Retinervus Luffae Fructus 20 parts, Bombyx Batryticatus 20 parts, Fructus Ligustri Lucidi 13 parts, Fructus Lycii 12 parts, Rhizoma Sparganii 10 parts, Radix Angelicae Sinensis 13 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 6 parts, Rhizoma Acori Graminei 8 parts, Pseudobulbus Cremastrae Seu Pleiones 9 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 8 parts, Herba Pileae Scriptae 9 parts, Herba Euphorbiae Humifusae 7 parts, 6 parts, Radix Glycyrrhizae;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 4
A kind of Chinese medicine composition for the treatment of gynecological tumor is made up of the crude drug of following weight portion: Rhizoma Curcumae 25 parts, Indigo Naturalis 35 parts, Herba Solani Nigri 23 parts, Cortex Albiziae 24 parts, Retinervus Luffae Fructus 23 parts, Bombyx Batryticatus 15 parts, Fructus Ligustri Lucidi 11 parts, Fructus Lycii 13 parts, Rhizoma Sparganii 14 parts, Radix Angelicae Sinensis 12 parts, Radix Stephaniae Japonicae 11 parts, Rhizoma Panacis Japonici 9 parts, Rhizoma Acori Graminei 6 parts, Pseudobulbus Cremastrae Seu Pleiones 6 parts, Herba Leonuri 8 parts, Cortex Magnoliae Officinalis 7 parts, Herba Pileae Scriptae 6 parts, Herba Euphorbiae Humifusae 8 parts, 9 parts, Radix Glycyrrhizae;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 5 Chinese medicine of the present invention is to the tumor-inhibiting action of ovarian cancer cell transplanted tumor in nude mice
Laboratory animal: BALB/c nude mice totally 20,7 ~ 9 week age, body weight 20 ~ 22g.
Tumor cell inoculation: the Proliferation of Human Ovarian Cell (Skov-3) of trophophase of taking the logarithm makes tumor cell suspension (1 × 10 7individual/ml), implant BALB/c nude mice armpit subcutaneous (about 0.3ml/ is only), the situations such as the rear routine observation mice spirit of inoculation, diet and defecation.Go down to posterity once, the identical 2mm of size is cut in aseptic for tumor tissues taking-up 3fritter, be seeded in nude mice armpit with the trocar subcutaneous.
Test grouping and method: the major diameter (a) of vernier caliper measurement tumor nodule, minor axis (b), by formula V=a × b 2× 0.52 calculates gross tumor volume, when subcutaneous transplantation tumor grows to 100mm 3after, select the nude mice that tumor size is consistent, being weighed by nude mice is divided into 3 groups with random digits table, is respectively negative control group, positive controls, Chinese medicine composition group of the present invention, often organizes 5 nude mices.Administration and being specifically grouped as follows: (1) negative control group: give normal saline; (2) 5-FU of positive drug control group: 30mg/kg; (3) Chinese medicine composition group of the present invention: 3.5g crude drug/kg; The each group of equal gastric infusion of mice.Every day is administered once, successive administration 30 days, after last administration 24h, takes out tumor block, measures tumor weight, finally calculate average tumor suppression ratio.Adopt SPSS software statistics, test data represents with (average ± standard deviation), and P is less than 0.01 for significant difference significant standard.Result of the test is in table 1.
Table 1 Chinese medicine composition of the present invention is to the inhibitory action result of the test of Skov-3 transplanted tumor in nude mice
Group Dosage (my god) Animal number of elements (only) Tumor heavy (g)
Negative control 5 1.98±0.78
5-FU 30mg/kg 5 0.63±0.51**
The present invention 3.5g crude drug/kg 5 0.66±0.32**
From the data of table 1, Chinese medicine composition of the present invention obviously can suppress the growth of gonad cell.
Embodiment 6: clinical data
1, physical data
Selection of clinical cervical cancer patient 100 example, 45-65 year, average 56.8 years old.
2, diagnostic criteria
Diagnosis of cervical cancer standard in " the Chinese common cancer diagnosis and treatment specification " compiled with China's Ministry of Public Health is for foundation.Clinical stages, all belongs to phase, phase, phase.
3, Therapeutic Method
Take medicine prepared by the embodiment of the present invention 1, sooner or later take at twice.It within 1 month, is 1 course for the treatment of.
4, efficacy assessment standard
According to Ministry of Public Health " Chinese common cancer diagnosis and treatment specification " cervical cancer efficacy assessment standard, so that before patient treatment, rear B ultrasonic or CT compare with treatment, complete incidence graph (CR), partial rcsponse (PR), stable (SD), progress (PD) carry out efficacy evaluation.
5, therapeutic outcome:
Result after 3 courses for the treatment of: complete incidence graph 31 example, partial rcsponse 45 example, stablizes 20 examples, progress 4 example.Coefficient of stabilization (CR+PR+SD) is 96%.

Claims (9)

1. treat a Chinese medicine composition for gynecological tumor, be made up of following bulk drugs: Rhizoma Curcumae, Indigo Naturalis, Herba Solani Nigri.
2. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 1, is made up of the crude drug of following weight portion: Rhizoma Curcumae 20-35 part, Indigo Naturalis 20-35 part, Herba Solani Nigri 15-25 part.
3. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 1, is made up of the crude drug of following weight portion: Rhizoma Curcumae 20-35 part, Indigo Naturalis 20-35 part, Herba Solani Nigri 15-25 part, Cortex Albiziae 15-25 part, Retinervus Luffae Fructus 15-25 part.
4. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 1, be made up of the crude drug of following weight portion: Rhizoma Curcumae 20-35 part, Indigo Naturalis 20-35 part, Herba Solani Nigri 15-25 part, Cortex Albiziae 15-25 part, Retinervus Luffae Fructus 15-25 part, Bombyx Batryticatus 15-25 part, Fructus Ligustri Lucidi 10-15 part, Fructus Lycii 10-15 part, Rhizoma Sparganii 10-15 part, Radix Angelicae Sinensis 10-15 part, Radix Stephaniae Japonicae 10-15 part, Rhizoma Panacis Japonici 5-10 part, Rhizoma Acori Graminei 5-10 part, Pseudobulbus Cremastrae Seu Pleiones 5-10 part, Herba Leonuri 5-10 part, Cortex Magnoliae Officinalis 5-10 part, Herba Pileae Scriptae 5-10 part, Herba Euphorbiae Humifusae 5-10 part, Radix Glycyrrhizae 5-10 part.
5. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 1, is made up of the crude drug of following weight portion: Rhizoma Curcumae 20 parts, Indigo Naturalis 20 parts, Herba Solani Nigri 25 parts, Cortex Albiziae 25 parts, Retinervus Luffae Fructus 15 parts, Bombyx Batryticatus 25 parts, Fructus Ligustri Lucidi 10 parts, Fructus Lycii 15 parts, Rhizoma Sparganii 15 parts, Radix Angelicae Sinensis 10 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 5 parts, Rhizoma Acori Graminei 10 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 10 parts, Herba Pileae Scriptae 5 parts, Herba Euphorbiae Humifusae 10 parts, 5 parts, Radix Glycyrrhizae.
6. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 1, is made up of the crude drug of following weight portion: Rhizoma Curcumae 30 parts, Indigo Naturalis 25 parts, Herba Solani Nigri 20 parts, Cortex Albiziae 23 parts, Retinervus Luffae Fructus 20 parts, Bombyx Batryticatus 20 parts, Fructus Ligustri Lucidi 13 parts, Fructus Lycii 12 parts, Rhizoma Sparganii 10 parts, Radix Angelicae Sinensis 13 parts, Radix Stephaniae Japonicae 15 parts, Rhizoma Panacis Japonici 6 parts, Rhizoma Acori Graminei 8 parts, Pseudobulbus Cremastrae Seu Pleiones 9 parts, Herba Leonuri 5 parts, Cortex Magnoliae Officinalis 8 parts, Herba Pileae Scriptae 9 parts, Herba Euphorbiae Humifusae 7 parts, 6 parts, Radix Glycyrrhizae.
7. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 1, is made up of the crude drug of following weight portion: Rhizoma Curcumae 25 parts, Indigo Naturalis 35 parts, Herba Solani Nigri 23 parts, Cortex Albiziae 24 parts, Retinervus Luffae Fructus 23 parts, Bombyx Batryticatus 15 parts, Fructus Ligustri Lucidi 11 parts, Fructus Lycii 13 parts, Rhizoma Sparganii 14 parts, Radix Angelicae Sinensis 12 parts, Radix Stephaniae Japonicae 11 parts, Rhizoma Panacis Japonici 9 parts, Rhizoma Acori Graminei 6 parts, Pseudobulbus Cremastrae Seu Pleiones 6 parts, Herba Leonuri 8 parts, Cortex Magnoliae Officinalis 7 parts, Herba Pileae Scriptae 6 parts, Herba Euphorbiae Humifusae 8 parts, 9 parts, Radix Glycyrrhizae.
8. a kind of Chinese medicine composition for the treatment of gynecological tumor described in any one of claim 1-7, is characterized in that, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.
9. a kind of Chinese medicine composition for the treatment of gynecological tumor according to claim 8, is characterized in that, described oral formulations is capsule, pill, powder, tablet, granule.
CN201510580257.3A 2015-09-14 2015-09-14 Traditional Chinese medicine composition for treating gynecological tumors Pending CN105031552A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510580257.3A CN105031552A (en) 2015-09-14 2015-09-14 Traditional Chinese medicine composition for treating gynecological tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510580257.3A CN105031552A (en) 2015-09-14 2015-09-14 Traditional Chinese medicine composition for treating gynecological tumors

Publications (1)

Publication Number Publication Date
CN105031552A true CN105031552A (en) 2015-11-11

Family

ID=54438911

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510580257.3A Pending CN105031552A (en) 2015-09-14 2015-09-14 Traditional Chinese medicine composition for treating gynecological tumors

Country Status (1)

Country Link
CN (1) CN105031552A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113521156A (en) * 2021-08-24 2021-10-22 苏州龙达生物科技有限公司 Traditional Chinese medicine composition for resisting HPV infection and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1192364A (en) * 1997-12-31 1998-09-09 苏新尚 Traditional Chinese medicine for treating gynecological tumour
CN102114023A (en) * 2010-09-27 2011-07-06 林秀坤 Oleanolic acid with anti-oophoroma action and pharmaceutical preparations thereof
CN104623567A (en) * 2015-03-16 2015-05-20 徐若曾 Blood circulation promoting and stasis removing traditional Chinese medicine preparation for treating breast cancer and preparation method of blood circulation promoting and stasis removing traditional Chinese medicine preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1192364A (en) * 1997-12-31 1998-09-09 苏新尚 Traditional Chinese medicine for treating gynecological tumour
CN102114023A (en) * 2010-09-27 2011-07-06 林秀坤 Oleanolic acid with anti-oophoroma action and pharmaceutical preparations thereof
CN104623567A (en) * 2015-03-16 2015-05-20 徐若曾 Blood circulation promoting and stasis removing traditional Chinese medicine preparation for treating breast cancer and preparation method of blood circulation promoting and stasis removing traditional Chinese medicine preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113521156A (en) * 2021-08-24 2021-10-22 苏州龙达生物科技有限公司 Traditional Chinese medicine composition for resisting HPV infection and preparation method thereof
CN113521156B (en) * 2021-08-24 2022-06-28 苏州龙达生物科技有限公司 Application of traditional Chinese medicine composition in preparation of medicine for resisting cervical precancerous lesions

Similar Documents

Publication Publication Date Title
CN105343625A (en) Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof
CN103169805A (en) Medicament for treating meniscus injury
CN105412787A (en) Medicine for treating postpartum irregular menstruation
CN103341092B (en) Preparation method of powder for treating atrophic vaginitis
CN102100877B (en) Medicament for treating ovarian infertility
CN106390021A (en) Pharmaceutical composition for preventing and treating uterine fibroid and ovarian cyst as well as preparation method, dosage form and application of pharmaceutical composition
CN103301353B (en) Pharmaceutical composition for treating atrophic vaginitis
CN103356932B (en) A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN104623376A (en) Medicament for treating prosopalgia
CN104324317A (en) Traditional Chinese medicine composition capable of treating uterine fibroids, and medicinal application
CN105031552A (en) Traditional Chinese medicine composition for treating gynecological tumors
CN103585596B (en) Traditional Chinese medicine composition for treating migraine
CN102824576A (en) Traditional Chinese medicinal composition for treating psoriasis and preparation method thereof
CN104887950A (en) Mastitis treatment traditional Chinese medicine compound
CN105168665A (en) Traditional Chinese medicinal composition for treating gynecological tumor
CN103330896B (en) Preparation method of powder for treating postpartum nonspecific vaginitis
CN103110722B (en) Traditional Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof
CN103301374B (en) Pharmaceutical composition for treating postpartum non-specificity vaginitis
CN103599253B (en) Traditional Chinese medicine composition for treating winter pruritus of old people
CN104645233A (en) Traditional Chinese medicine preparation for treating hyperplasia of mammary glands
CN105288315A (en) Christina loosestrife herb oral liquid for clearing away heat, removing dampness, benefiting bile and expelling toxin and preparation method of christina loosestrife herb oral liquid
CN104338086A (en) Chinese medicinal enema for treating chronic endometritis and preparation method thereof
CN104840814A (en) Traditional Chinese medicine combination for treating senile femoral head necrosis
CN104707124A (en) Traditional Chinese medicine preparation for treating chronic endometritis
CN104524149A (en) Pharmaceutical composition for preventing and treating acute nephritis and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151111

WD01 Invention patent application deemed withdrawn after publication